Generation of antibodies against prion protein in wild-type mice via helix 1 peptide immunization
被引:26
作者:
Arbel, M
论文数: 0引用数: 0
h-index: 0
机构:
Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, IsraelTel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel
Arbel, M
[1
]
Lavie, V
论文数: 0引用数: 0
h-index: 0
机构:
Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, IsraelTel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel
Lavie, V
[1
]
Solomon, B
论文数: 0引用数: 0
h-index: 0
机构:
Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, IsraelTel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel
Solomon, B
[1
]
机构:
[1] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel
prion protein;
active immunization;
anti-PrP antibodies;
helix;
1;
D O I:
10.1016/j.jneuroim.2003.08.036
中图分类号:
R392 [医学免疫学];
Q939.91 [免疫学];
学科分类号:
100102 ;
摘要:
We present here the development of antibodies against prion protein in BALB/C mice using as antigen human helix I of PrP. This sequence is suggested to be involved in protein pathological conformational changes, and is distinguished from that of mice by one amino acid. The immune tolerance to an 'almost-self' epitope and the poor immunogenicity of short peptides was overcome by using Multiple Antigen Peptide displaying eight copies of helix 1. The generated antibodies recognize the whole prion protein with a high binding constant and the established protocol may lead to an active immunization towards therapeutics of prion disease. (C) 2003 Elsevier B.V. All rights reserved.
机构:
Imperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, EnglandImperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, England
Enari, M
;
Flechsig, E
论文数: 0引用数: 0
h-index: 0
机构:
Imperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, EnglandImperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, England
Flechsig, E
;
Weissmann, C
论文数: 0引用数: 0
h-index: 0
机构:
Imperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, EnglandImperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, England
机构:Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel
Hanan, E
;
Priola, SA
论文数: 0引用数: 0
h-index: 0
机构:Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel
Priola, SA
;
Solomon, B
论文数: 0引用数: 0
h-index: 0
机构:
Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, IsraelTel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel
机构:
Imperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, EnglandImperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, England
Enari, M
;
Flechsig, E
论文数: 0引用数: 0
h-index: 0
机构:
Imperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, EnglandImperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, England
Flechsig, E
;
Weissmann, C
论文数: 0引用数: 0
h-index: 0
机构:
Imperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, EnglandImperial Coll Sch Med St Marys, Med Res Council Prion Unit, London W2 1PG, England
机构:Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel
Hanan, E
;
Priola, SA
论文数: 0引用数: 0
h-index: 0
机构:Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel
Priola, SA
;
Solomon, B
论文数: 0引用数: 0
h-index: 0
机构:
Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, IsraelTel Aviv Univ, Dept Mol Microbiol & Biotechnol, Fac Life Sci, IL-69978 Tel Aviv, Israel